Literature DB >> 2808393

Autophosphorylation activates the soluble cytoplasmic domain of the insulin receptor in an intermolecular reaction.

M H Cobb1, B C Sang, R Gonzalez, E Goldsmith, L Ellis.   

Abstract

The cytoplasmic protein-tyrosine kinase domain of the insulin receptor (residues 959-1355) has been expressed as a soluble protein in Sf9 insect cells via a Baculovirus expression vector (Ellis, L., Levitan, A., Cobb, M.H., and Ramos, P. (1988) J. Virol. 62, 1634-1639). The purified protein is a monomer as judged by its behavior in sucrose gradients and on gel filtration in the presence or absence of protamine. The initial rate of autophosphorylation using 3 mM MgCl2 is increased 20-30-fold by protamine. A maximum of 4-5 mol of phosphate are incorporated per mol of enzyme. The activity of the enzyme as a function of phosphorylation state was studied for three substrates: a synthetic dodecapeptide derived from the sequence of the major autophosphorylation site in the insulin receptor, poly(Glu, Tyr), 4:1, and histone 2B. Autophosphorylation of the protein to a stoichiometry of 4-5 mol of phosphate/mol increases its enzymatic activity as much as 200-fold; a 30-fold increase in activity occurs upon addition of 1 mol of phosphate/mol. The activities of unphosphorylated enzyme with the three substrates are 3.4, 2.3, and 0.44 nmol/min/mg, respectively. The activities of the autophosphorylated enzyme with the three substrates are 175, 274, and 45 nmol/min/mg, respectively. Exposure of the autophosphorylated enzyme to ADP results in a loss of phosphate from the enzyme which is associated with a decrease in enzymatic activity. Autophosphorylation of the kinase in the presence or absence of protamine displays a marked dependence on enzyme concentration. Furthermore, the rate of autophosphorylation decreases as the viscosity of the solution increases. Taken together, these data suggest that phosphorylation occurs via an intermolecular reaction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2808393

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma.

Authors:  Scott C Bresler; Andrew C Wood; Elizabeth A Haglund; Joshua Courtright; Lili T Belcastro; Jefferson S Plegaria; Kristina Cole; Yana Toporovskaya; Huaqing Zhao; Erica L Carpenter; James G Christensen; John M Maris; Mark A Lemmon; Yaël P Mossé
Journal:  Sci Transl Med       Date:  2011-11-09       Impact factor: 17.956

2.  Mechanoenzymatics of titin kinase.

Authors:  Elias M Puchner; Alexander Alexandrovich; Ay Lin Kho; Ulf Hensen; Lars V Schäfer; Birgit Brandmeier; Frauke Gräter; Helmut Grubmüller; Hermann E Gaub; Mathias Gautel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-02       Impact factor: 11.205

3.  Mechanism of activation for Zap-70 catalytic activity.

Authors:  P V LoGrasso; J Hawkins; L J Frank; D Wisniewski; A Marcy
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

4.  Human biliverdin reductase-based peptides activate and inhibit glucose uptake through direct interaction with the kinase domain of insulin receptor.

Authors:  Peter E M Gibbs; Nicole Lerner-Marmarosh; Amelia Poulin; Elie Farah; Mahin D Maines
Journal:  FASEB J       Date:  2014-02-25       Impact factor: 5.191

5.  ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation.

Authors:  Fumin Shi; Shannon E Telesco; Yingting Liu; Ravi Radhakrishnan; Mark A Lemmon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

6.  Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein.

Authors:  S L Sierke; K Cheng; H H Kim; J G Koland
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

7.  Changes in insulin-receptor tyrosine, serine and threonine phosphorylation as a result of substitution of tyrosine-1162 with phenylalanine.

Authors:  J M Tavaré; M Dickens
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

Review 8.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

9.  Identification of the glycogenic compound 5-iodotubercidin as a general protein kinase inhibitor.

Authors:  D Massillon; W Stalmans; G van de Werve; M Bollen
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

10.  Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies.

Authors:  T G Boulton; M H Cobb
Journal:  Cell Regul       Date:  1991-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.